Himalaya Shipping HSHP
$14.58 −$0.28 (-1.88%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $14.58 0.00%
Open$14.86
Prev close$14.86
Day range$14.54 – $15.14
Volume403.9K
Market cap$687.74M
P/E (TTM)9.0
Dividend yield11.25%
Earnings
Average move on report day±2.7%last 15 reports
Closed higher9 of 1560% of the time
Best reaction+5.7%
Worst reaction-7.9%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 11 Nov 2026 | None | – | +3.26% | – |
| 2026/Q2 | 11 Aug 2026 | None | – | +1.31% | – |
| 2026/Q1 | 21 May 2026 | Pre Market | – | -0.98% | – |
| 2025/Q4 | 10 Feb 2026 | None | – | +5.69% | – |
| 2025/Q3 | 6 Nov 2025 | None | – | +0.66% | – |
| 2025/Q2 | 8 Aug 2025 | None | – | -0.97% | – |
| 2025/Q1 | 22 May 2025 | None | – | +0.54% | – |
| 2024/Q4 | 20 Feb 2025 | None | – | +4.36% | – |
| 2024/Q3 | 7 Nov 2024 | None | – | +1.14% | – |
| 2024/Q2 | 16 Aug 2024 | Pre Market | – | -2.70% | – |
| 2024/Q1 | 23 May 2024 | None | – | -2.63% | – |
| 2023/Q4 | 15 Feb 2024 | None | – | +3.19% | – |
| 2023/Q3 | 17 Nov 2023 | None | – | +1.38% | – |
| 2023/Q2 | 8 Aug 2023 | None | – | -3.11% | – |
| 2023/Q1 | 24 May 2023 | None | – | -7.87% | – |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$62.60M+65.2% YoY
Operating profit$45.40M+106.4% YoY
Net profit$33.30M+250.5% YoY
Diluted EPS$0.71+238.1% YoY
Free cash flow$43.80M+139.3% YoY
Operating cash flow$43.80M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin68.3%
Operating margin65.2%
Net margin39.8%
Return on equity47.2%
Return on assets8.9%
Return on invested capital14.8%
Current ratio1.22
Liabilities / assets80.7%
Cash & investments$39.70M
Total debt$671.60M
Net cash (debt)-$631.90M
Free cash flow / sales58.6%
No comments yet — be the first to weigh in on HSHP.
Sign in to join the discussion.